Chemed (CHE) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Chemed (CHE) do?
Chemed Corp (CHE) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Provides hospice and palliative care services to patients facing terminal illnesses through specialized medical personnel. Operates nationwide end-of-life hospice care alongside a separate national residential plumbing and drain cleaning. It is worth $7.18B on the market and sold $2.66B over the last year.
- Market cap
- $7.18B
- P/E ratio
- 26.4×
- Annual sales
- $2.66B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 10, 2026
Brands and businesses behind CHE
- VITAS Healthcare: Delivers hospice and palliative care to terminal patients, collecting payments primarily through Medicare and Medicaid reimbursements.
- Roto-Rooter: Offers emergency plumbing, drain cleaning, and water restoration services, charging fees directly to property owners and insurers.
CHE’s flags, in plain English
Each flag is a number from Chemed’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 10, 2026.
Earns Its Keep
Earns 29.1% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.
Capital Works Hard
Earns 23.3% a year on the money it invests in the business. The money in the business, from shareholders and lenders together, earns a strong return. That points to a company that picks its investments well.
Low debt
Low debt, only 48% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Worth a Look
VITAS relies on Medicare and Medicaid for almost all hospice revenue, leaving income vulnerable to federal reimbursement policy changes. Something here could change the picture, so it is worth reading next to the good news.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about CHE
How big is Chemed?
Chemed’s market cap is $7.18B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $2.66B: what customers paid the company over the last year, before any costs.
What is CHE’s P/E ratio?
CHE’s P/E ratio is 26.4×. Investors pay about 26.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with CHE?
The first risk note on the card is Worth a Look, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Chemed’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. CHE’s filings on SEC.gov. The Margin Monkey is research, not advice.
